MedPath

Pilot study of the feasibility of research on the application of bright light as a means of restoring the sleep-wake rhythm in patients with schizophrenia admitted to the locked ward, and by that means alleviating their psychotic symptoms.

Phase 2
Completed
Conditions
disturbed circadian rhythm in schizophrenia
10039628
Registration Number
NL-OMON33052
Lead Sponsor
Parnassia (Den Haag)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

- All patients diagnosed with schizophrenia or schizoaffective disorder by a psychiatrist according to the DSM-IV TR classification.
- Patients who are admitted to the clinical institution KCVG.
- Patients for whom informed consent and informed consent by proxy has been given.

Exclusion Criteria

- Patients with diagnosis of bipolar disorder.
- Patients with a current manic episode measured with the Young Mania Rating Scale.
- Patients with contra-indications for light therapy after eye examination, such as glaucoma, retinopathy or cataracts.
- Patients with epilepsy in history or at present

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The main study parameter is the change from baseline to endpoint in level of<br /><br>psychosis measured with the PANSS.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study parameter is the change in the sleep-wake rhythm and<br /><br>activities measured with a sleep log and a social rhythm therapy scheme. </p><br>
© Copyright 2025. All Rights Reserved by MedPath